The FDA's Gene-Therapy Reversal and the Exit of Vinay Prasad
WSJ Opinion: Potomac Watch
00:00
FDA's Gene Therapy Pause: Implications for Medical Innovation
This chapter examines the FDA's significant halt on the gene therapy Elevitis, triggered by the deaths of two patients. It delves into the broader implications for medical regulation, drug approval processes, and the future of gene therapy for rare diseases.
Transcript
Play full episode
